Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

Advanced therapy medical products (ATMPs) are rapidly growing as innovative medicines for the treatment of several diseases. Hence, the role of quality analytical tests to ensure consistent product safety and quality has become highly relevant. Several clinical trials involving dendritic cell (DC)-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pancisi, Elena, Granato, Anna Maria, Scarpi, Emanuela, Ridolfi, Laura, Carloni, Silvia, Moretti, Cinzia, Guidoboni, Massimo, De Rosa, Francesco, Pignatta, Sara, Piccinini, Claudia, Soldati, Valentina, Calabrò, Luana, Framarini, Massimo, Stefanelli, Monica, Bulgarelli, Jenny, Tazzari, Marcella, Fanini, Francesca, Petrini, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323699/
https://www.ncbi.nlm.nih.gov/pubmed/35891165
http://dx.doi.org/10.3390/vaccines10070999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323699/
https://www.ncbi.nlm.nih.gov/pubmed/35891165
http://dx.doi.org/10.3390/vaccines10070999

Ejemplares similares